USPTO serial 88363340
COLLADERM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEVERSON, JUSTIN
- Law office
- TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with COLLADERM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Bone cement for medical purposes; Bone cement for surgical and orthopaedic purposes; Bone cement for surgical and orthopedic purposes; Bone fillers consisting of living materials; Bone growth media consisting of biological materials for medical purposes; Bone morphogenetic protein for use as a bone growth media; Bone paste for medical purposes; Bone repair paste for use in orthopedic surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Bone wax for use in surgical procedures; Collagen for medical purposes; Allograft tissue reconstitution solution kits; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Biological tissue grafts; Biological implants, namely, a vital processed human or animal connective tissue; Biological collagen tissue intended for subsequent implantation; Culture media for use in tissue grafting; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Human allograft tissue; Human allograft bone and tissue; Implantable scaffolds comprising living tissue for enhancing therapy; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Media for use in the augmentation of bone and tissue for medical purposes; Medical adhesives for binding internal tissue; Medicated pre-moistened tissues; Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pre-moistened medicated tissues; Processed human donor skin for the replacement of soft tissue; Surgical implants comprised of living tissues; Surgical implants comprising living tissue; Surgical mesh comprised primarily of living tissue; Therapeutic agents for delivery of oxygen to animal tissue; Therapeutic agents for delivery of oxygen to human tissue; Vascular grafts | ACTIVE | — |
| 010 | Bone prostheses; Bone void filler consisting of synthetic materials; Bone void fillers consisting of artificial materials; Bone void fillers consisting primarily of synthetic materials and also incorporating biological materials; Artificial bone growth media; Artificial bone parts to be implanted in natural bones; Artificial bones for implantation; Artificial biomaterials for augmentation of bone and tissue for medical purposes; Dental and medical drill bits for cutting teeth or bone; Implantable scaffolds comprising artificial materials for maintaining tissue contour; Light-based medical devices, namely, a light emitting diode (LED) device for increasing the human body's own production of collagen; Medical and surgical cutters for cutting human or animal tissue and organs; Medical and surgical knives and cutters for cutting human or animal tissue and organs; Medical and surgical knives for cutting human or animal tissue and organs; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Medical instruments for cutting tissue; Medical instruments for interstitial thermotherapy of biological tissue; Medical specimen bags for holding body tissue samples for testing purposes; Prosthetic tissues for parietal, visceral and vascular use; Substitutes for bones, cartilage, ligaments and tendons; Surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Synthetic filler and extender material to serve as replacement for bone; Synthetic media for use in the augmentation of bone and tissue for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 30, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 30, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 17, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 17, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2019 | NWAP | NEW APPLICATION ENTERED | — |